Spondilite anchilosante, ridurre la dose di farmaco anti-TNF si pu
Pharmastar Italy,
Stando ai risultati di uno studio appena pubblicato su Arthritis Research
Stando ai risultati di uno studio appena pubblicato su Arthritis Research
medwireNews : A dose-reduction strategy may be feasible for ankylosing spondylitis (AS) patients in sustained clinical…
21-01-2019 | Rheumatology | News | Article medwireNews: A dose-reduction strategy may be feasible for ankylosing spondylitis (AS…
Related Biotechnology, Pharmaceutical and Healthcare News The objective was to determine if dose reduction is non-inferior to…